Clinical Trials Directory

Trials / Completed

CompletedNCT03848013

Treatment of Melasma Using Q-switched Nd: YAG Laser and Fractional CO2 Laser Separately and in Combination

Reatment of Melasma Using Q-switched Nd: YAG Laser and Fractional CO2 Laser Separately and in Combination

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Kasr El Aini Hospital · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

* All participants will be divided into 2 groups : Group A \& Group B. * Group A will be subjected to 3 consecutive sessions of Q-switched 1,064 nm Nd: YAG laser to one side of the face \& fractional co2 laser to the other side of the face with one month interval between sessions. * Group B will be subjected also to 3 consecutive sessions of Q-switched 1,064 nm Nd: YAG laser to one side of the face \& an additional fractional co2 laser to the other side of the face using the above mentioned parameters with one month interval between sessions. * Response to treatment will be assessed using the Melanin Index (MI) score, Melasma Area and Severity Index (MASI) score, spectrophotometer ( Derma catch, colorix, Neuchatel, Switzerland ) and a subjective self-assessment method.

Conditions

Interventions

TypeNameDescription
DEVICEQ switched Nd YAG laserLaser device emitting Q switched Nd YAG aiming for skin toning
DEVICEFractional CO2 laserLaser device emitting fractionated ablative laser aiming for skin resurfacing

Timeline

Start date
2017-01-01
Primary completion
2019-04-01
Completion
2019-06-01
First posted
2019-02-20
Last updated
2020-01-10

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03848013. Inclusion in this directory is not an endorsement.